Skip to Content

Join the 'Vecuronium' group to help and get support from people like you.

Vecuronium News

Forward-Thinking Tips for Back Pain

Posted 19 Jan 2017 by Drugs.com

WEDNESDAY, Jan. 18, 2017 – Back pain is common but not inevitable, an orthopedist says. Roughly eight out of 10 people will suffer significant back pain at least once in their lifetime – but there are ways to reduce the risk, said Dr. Mark Knaub of Penn State Hershey Medical Center. Muscle, ligament or tendon strains (soft tissue injuries) are the most common causes of back pain. These injuries ...

FDA Approves Bridion (sugammadex) to Reverse Effects of Neuromuscular Blocking Drugs

Posted 17 Dec 2015 by Drugs.com

December 15, 2015 – The U.S. Food and Drug Administration today approved Bridion (sugammadex) injection to reverse the effects of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide, which are used during certain types of surgery in adults. Rocuronium bromide and vecuronium bromide are neuromuscular blocking drugs that cause temporary paralysis by interfering with the ...

Bridion Approved to Reverse Effects of Surgical Drugs

Posted 16 Dec 2015 by Drugs.com

TUESDAY, Dec. 15, 2015 – Bridion (sugammadex) has been approved by the U.S. Food and Drug Administration to reverse the effects of medications that are used to paralyze the vocal chords during certain surgical procedures. Rocuronium bromide and vecuronium bromide are prescribed when surgeons use an artificial airway or breathing tube, a process called tracheal intubation, the FDA said Tuesday in ...

FDA Medwatch Alert: Vecuronium Bromide For Injection by Sagent Pharmaceuticals, Inc.: Recall - Elevated Impurity Result Detected

Posted 11 Jun 2013 by Drugs.com

ISSUE: Sagent Pharmaceuticals, Inc. announced the voluntary nationwide recall of three lots of Vecuronium Bromide for Injection 10mg (NDC number 25021-657-10) manufactured by Mustafa Nevzat Ilac Sanayii A.S. (MN Pharmaceuticals) and distributed by Sagent.  Sagent has initiated this voluntary recall of Vecuronium Bromide for Injection to the user level due to the  discovery of an elevated impurity ...

FDA Medwatch Alert: Vecuronium Bromide For Injection Preservative Free (Bedford Laboratories): Recall - Particulate Matter

Posted 4 Jul 2012 by Drugs.com

  [Posted 06/29/2012] ISSUE: Bedford Laboratories issued recall of Vecuronium Bromide For Injection, 20 mg vial – NDC #55390-039-10, Lot 2067134, Exp. Date 5/31/2013 - due to the discovery of particulate matter in a small number of vials. This recall is for lot 2067134 only. Particulate matter has been recognized as a potential health hazard. Adverse reactions may include vein irritation and ph ...

FDA Medwatch Alert: Bedford Laboratories Polymyxin B For Injection USP And Vecuronium Bromide For Injection: Recall - Glass Particles

Posted 13 Jan 2012 by Drugs.com

ISSUE: Bedford Laboratories issued guidance on the nationwide voluntary product recalls originally issued on August 2, 2011. The recalls were initiated after the discovery of a visible glass particle in a limited number of vials within the lots listed below to the user level. Polymyxin B for Injection USP, 500,000 Units per vial – NDC #55390-139-10 Lot 1942980 – Exp. Date August 2013 and Lot 1895 ...

Ask a Question

Further Information

Related Condition Support Groups

Anesthesia

Related Drug Support Groups

Norcuron

Vecuronium Patient Information at Drugs.com